Read, Write, Understand the Code of Life
febit's innovative microarray technologies
Are you looking for a DNA/RNA analysis solution that is able to adapt to your changing demands?
Stop searching - start working today: Products and Services based on the Geniom® Technology allow you to obtain efficient and reliable microarray experimentation results from any sequence information very fast.
miRNA Profiling Service with miRBase 12.0
The miRBase is a continuously updated database for miRNA sequences maintained by the Sanger Institute. febit provides services from sample to bioinformatic report based always on the latest miRBase content.
HybSelect Early Access
A method for capturing the genetic region of interest for a next generation sequencing run, saving time, costs and technical resources.
The human genome as an RNA machine
Abstract: The human genome contains about 20,000 protein-coding genes, surprisingly the same number as those in tiny worms.
-
19. November 2008
febit Announces Strategic Investment and Technology Development Agreement with In-Q-Tel
febit group today announced a strategic investment and technology development agreement with In-Q-Tel, the independent strategic investment firm that identifies innovative technology solutions to support the mission of the broader U.S. Intelligence Community.
-
20. Oktober 2008
The German Cancer Research Center Investigates the Role of miRNAs in Carcinogenesis Using febits Geniom RT Analyzer
The German Cancer Research Center, also known as DKFZ, in Heidelberg (Germany) chose febit´s newly introduced Geniom® RT Analyzer to investigate the association of microRNAs (miRNAs) and cancer.
-
1. September 2008
febit first to offer Geniom Biochips based on miRBase 12.0
Today febit announced its latest miRNA Biochip based on the new miRBase version 12.0 which has been released by the Wellcome Trust Sanger Institute early this afternoon.
-
19. November 2008
febit Announces Strategic Investment and Technology Development Agreement with In-Q-Tel
febit group today announced a strategic investment and technology development agreement with In-Q-Tel, the independent strategic investment firm that identifies innovative technology solutions to support the mission of the broader U.S. Intelligence Community.
-
20. Oktober 2008
The German Cancer Research Center Investigates the Role of miRNAs in Carcinogenesis Using febits Geniom RT Analyzer
The German Cancer Research Center, also known as DKFZ, in Heidelberg (Germany) chose febit´s newly introduced Geniom® RT Analyzer to investigate the association of microRNAs (miRNAs) and cancer.
-
1. September 2008
febit first to offer Geniom Biochips based on miRBase 12.0
Today febit announced its latest miRNA Biochip based on the new miRBase version 12.0 which has been released by the Wellcome Trust Sanger Institute early this afternoon.
